Skip To Main Content
Suneel Kamath on Muck Rack

Suneel Kamath

  • Fellow - Northwestern Medicine
Cleveland
As seen in: Wiley, Wiley Online Library, The Oncologist, Chicago Tribune, MDPI, U.S. News and World Report, STAT, MedPage Today, Healio Gastroenterology, HemOnc Today and
GI #Oncologist @ClevelandClinic

Get in touch with Suneel

Contact Suneel, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

‘Transformational’: Daraxonrasib data signal ‘new era’ in pancreatic cancer

|
By Mark Leiser Verified, Heather Biele Verified, Suneel Kamath
| Citeline Verified
Loading the Elevenlabs Text to Speech AudioNative Player... The eagerly awaited full dataset from the most pivotal pancreatic cancer study in decades didn’t just live up to expectations. It far exceeded them. Image: Dana-Farber Cancer Center. Reprinted with permission.
Open in Who Shared Issue with article?

The Advent of Perioperative Immunotherapy in Early-Stage Hepatocellular Carcinoma

|
By Suneel Kamath
| NEJM Journal Watch Verified
Suneel D. Kamath, M.D., reviewing Perioperative camrelizumab plus rivoceranib more than doubles event-free survival compared with surgery alone in select patients with hepatocellular carcinoma. Even with optimal surgical resection, up to 80% of patients with early-stage hepatocellular carcinoma (HCC) experience recurrence, particularly those with bulky tumors or vascular invasion. Numerous adjuvant therapies, including atezolizumab and bevacizumab, have failed to improve outcomes.
Open in Who Shared Issue with article?

Exercise as Medicine for Preventing Colon Cancer Recurrence

|
By Suneel Kamath, Vlad G. Zaha
| NEJM Journal Watch Verified
Suneel D. Kamath, MD and Vlad G. Zaha, MD, PhD, FACC, FAHA, reviewing Structured exercise significantly reduces recurrence risk and improves survival for stage II and III colon cancer. While outcomes after surgery and adjuvant chemotherapy for stage II/III colon cancer are generally good, cancer still recurs in about 30% of patients, and quality of life and cardiorespiratory fitness are decreased.
Open in Who Shared Issue with article?
See all 51 licensed articles (79 Total)